Thus, additional statistics are necessary for more credible results, and further studies are expected to explore whether ZEB1 is the sole transcription factor related to drug resistance in breast cancer, as well as the regulatory mechanism responsible for miRNA-129-5p on ZEB1. Here, ZEB1 is linked to breast carcinoma.